한글목차

HRM(High-Resolution Melting) 시장 규모는 2025년 4억 4,364만 달러에서 2034년에는 9억 3,372만 달러에 이를 것으로 예측되며, 2026-2034년 CAGR 8.62%로 성장할 전망입니다.

HRM(High-Resolution Melting)(HRM) 분석 시장은 정밀한 유전자 분석 및 분자진단에 대한 수요가 증가함에 따라 괄목할 만한 성장이 예상됩니다. HRM은 DNA 돌연변이를 분석하는 강력한 기술로, 연구, 임상 진단, 개인 맞춤형 의료에 적용될 때 필수적인 신속하고 정확한 결과를 제공합니다. 유전성 질환 증가 추세와 효과적인 스크리닝 기법의 필요성이 높아지면서 다양한 의료 현장에서 HRM 기술의 도입이 진행되고 있습니다. 연구자와 임상의가 유전자 변이에 대한 이해를 높이기 위해 노력하고 있는 가운데, HRM은 분자생물학 툴킷에서 필수적인 수단으로 부상하고 있습니다.

기술 발전으로 인해 고해상도 용융 분석 능력이 향상되어 접근성과 효율성이 향상되었습니다. 장비와 소프트웨어의 혁신으로 HRM의 민감도와 특이도가 향상되어 미세한 유전자 변이도 검출할 수 있게 되었습니다. 또한, 차세대 시퀀싱 기술과의 통합으로 응용 범위가 확대되어 기존에는 불가능했던 종합적인 유전체 분석을 실현하고 있습니다. 유전체학 분야가 계속 진화하는 가운데 HRM과 같은 신뢰성 높은 고처리량 분석 기법에 대한 수요는 더욱 높아질 것이며, 현대 유전자 연구의 기반 기술로 자리매김할 것으로 예측됩니다.

또한, 개인 맞춤형 의료에 대한 관심이 높아지면서 HRM 분석 시장의 성장을 가속할 것으로 예측됩니다. 의료가 개인 유전자 프로파일에 기반한 맞춤형 치료로 전환하는 가운데, 유전자 변이를 신속하고 정확하게 평가할 수 있는 능력은 매우 중요합니다. 암 진단, 감염성 질환 진단 등 다양한 응용 분야에서 HRM의 임상적 유용성을 뒷받침하는 연구들이 축적되면서 그 보급이 더욱 가속화될 것으로 예측됩니다. 결론적으로, HRM(High-Resolution Melting) 분석 시장은 기술 혁신, 정밀의료에 대한 수요, 그리고 의료 분야에서의 유전자 분석 적용 확대에 힘입어 괄목할 만한 성장을 이룰 것으로 예측됩니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 HRM(High-Resolution Melting) 분석 시장 : 제품 유형별

제5장 세계의 HRM(High-Resolution Melting) 분석 시장 : 용도별

제6장 세계의 HRM(High-Resolution Melting) 분석 시장 : 최종사용자별

제7장 세계의 HRM(High-Resolution Melting) 분석 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

영문목차

The High-Resolution Melting Analysis Market size is expected to reach USD 933.72 Million in 2034 from USD 443.64 Million (2025) growing at a CAGR of 8.62% during 2026-2034.

The high-resolution melting (HRM) analysis market is poised for significant growth as the demand for precise genetic analysis and molecular diagnostics escalates. HRM is a powerful technique used to analyze DNA variations, providing rapid and accurate results that are essential for applications in research, clinical diagnostics, and personalized medicine. The increasing prevalence of genetic disorders and the need for effective screening methods are driving the adoption of HRM technology across various healthcare settings. As researchers and clinicians seek to enhance their understanding of genetic variations, HRM is emerging as a vital tool in the molecular biology toolkit.

Technological advancements are propelling the capabilities of high-resolution melting analysis, making it more accessible and efficient. Innovations in instrumentation and software are enhancing the sensitivity and specificity of HRM, allowing for the detection of even subtle genetic variations. Furthermore, the integration of HRM with next-generation sequencing technologies is expanding its applications, enabling comprehensive genomic analyses that were previously unattainable. As the field of genomics continues to evolve, the demand for reliable and high-throughput analysis methods like HRM is expected to grow, positioning it as a cornerstone of modern genetic research.

Additionally, the increasing focus on personalized medicine is likely to drive the HRM analysis market forward. As healthcare shifts towards tailored treatment approaches based on individual genetic profiles, the ability to quickly and accurately assess genetic variations becomes paramount. The growing body of research supporting the clinical utility of HRM in various applications, including cancer diagnostics and infectious disease detection, is expected to further accelerate its adoption. In conclusion, the high-resolution melting analysis market is set for remarkable growth, driven by technological innovation, the demand for precision medicine, and the expanding applications of genetic analysis in healthcare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Reagents And Consumables
• Instruments
• Software

By Application

• SNP Genotyping
• Mutation Discovery
• Epigenetics
• Species Identification
• Others

By End-User

• Research Laboratories
• Pharmaceutical And Biotechnology Companies
• Academic And Research Institutes
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, BioRad Laboratories Inc, F HoffmannLa Roche Ltd, Qiagen NV, Agilent Technologies Inc, Illumina Inc, Merck KGaA, Promega Corporation, bioMrieux SA, Takara Bio Inc, SigmaAldrich Corporation, Canon BioMedical Inc, Idaho Technology Inc, Premier Biosoft, Zymo Research Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Reagents And Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. SNP Genotyping Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Mutation Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Epigenetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Species Identification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pharmaceutical And Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HIGH-RESOLUTION MELTING ANALYSIS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HIGH-RESOLUTION MELTING ANALYSIS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Bio-Rad Laboratories Inc
  • 9.2.3 F. Hoffmann-La Roche Ltd
  • 9.2.4 Qiagen N.V
  • 9.2.5 Agilent Technologies Inc
  • 9.2.6 Illumina Inc
  • 9.2.7 Merck KGaA
  • 9.2.8 Promega Corporation
  • 9.2.9 BioMAfA(C)Rieux S.A
  • 9.2.10 Takara Bio Inc
  • 9.2.11 Sigma-Aldrich Corporation
  • 9.2.12 Canon BioMedical Inc
  • 9.2.13 Idaho Technology Inc
  • 9.2.14 Premier Biosoft
  • 9.2.15 Zymo Research Corporation